Health disparities in cost of care in patients with Alzheimer's disease: An analysis across 4 state medicaid populations

American Journal of Alzheimer's Disease and other Dementias

Volumn 28, Issue 1, 2013, Pages 84-92

  Gilligan, Adrienne M ^a   Malone, Daniel C ^a   Warholak, Terri L ^a   Armstrong, Edward P ^a  

^a Pharmacy Pulido Center   (United States)

Author keywords

Alzheimer's disease; Costs; Health disparities; Medicaid

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; COST OF ILLNESS; FEMALE; HEALTH CARE COST; HEALTH DISPARITY; HISPANIC; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; NEGRO; RETROSPECTIVE STUDY; UNITED STATES;

EID: 84876487523     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317512467679     Document Type: Article

References (41)

1. Alzheimer's Association. 2012 Alzheimer's disease facts and figures. Alzheimers Dement. 2012;8(2):131-168.
2. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60(8):1119-1122. (Pubitemid 36975801)
3. Demirovic J, Prineas R, Loewenstein D, et al. Prevalence of dementia in three ethnic groups: the South Florida program on aging and health. Ann Epidemiol. 2003;13(6):472-478. (Pubitemid 36870817)
4. Tang MX, Cross P, Andrews H, et al. Incidence of AD in African-Americans, Caribbean hispanics, and caucasians in Northern Manhattan. Neurology. 2001;56(1):49-56. (Pubitemid 32059651)
5. Griffith P, Lichtenberg P, Goldman R, et al. Safety and efficacy of donepezil in African-Americans with mild-To-moderate Alzheimer's disease. J Natl Med Assoc. 2006;98(10):1590-1597. (Pubitemid 44682951)
6. Hargrave R, Stoeklin M, Haan M, Reed B. Clinical aspects of Alzheimer's disease in black and white patients. J Natl Med Assoc. 1998;90(2):78-84. (Pubitemid 128454294)
7. Shadlen MF, Larson EB, Gibbons L, McCormick WC, Teri L. Alzheimer's disease symptom severity in blacks and whites. J Am Geriatr Soc. 1999;47(4):482-486. (Pubitemid 29181377)
8. Lopez OL, Mackell JA, Sun Y, et al. Effectiveness and safety of donepezil in hispanic patients with Alzheimer's disease: a 12-week open-label study. J NatlMed Assoc. 2008;100(11):1350-1358.
9. The Lewin Group. Lewin Model on Alzheimer's and dementia and costs. The model estimates total payments for community-based health care services using data from the Medicare Current Beneficiary Survey (MCBS). Its methodology is www.alz.org/trajectory.
10. Medicare Current Beneficiary Survey for 2008. Prepared under contract by Julie Bynum, MD, MPH, Dartmouth Institute for Health Policy and Clinical Care, Dartmouth Medical School, November 2011.
11. Menzin J, Lang K, Friedman M, Neumann P, Cummings JL. The economic cost of Alzheimer's disease and related dementias to the California Medicaid program ("Medi-Cal") in 1995. Am J Geriatr Psychiatry. 1999;7(4):300-308. (Pubitemid 29468657)
12. Martin BC, Ricci JF, Kotzan JA, Lang K, Menzin J. The net cost of Alzheimer disease and related dementia: a population-based study of Georgia Medicaid recipients. Alzheimer Dis Assoc Disord. 2000;14(3):151-159.
13. Solberg LI, Parker ED, Foldes SS, Walker PF. Disparities in tobacco cessation medication orders and fills among special populations. Nicotine Tob Res. 2010;12(2):144-151.
14. Brady J, Ho K, Kelley E, Clancy CM. AHRQs national healthcare quality and disparities reports: an ever-expanding road map for improvement. Health Serv Res. 2007;42(3 pt 1):6-21.
15. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academy Press; 2001.
16. Jencks SF, Cuerdon T, Burwen DR, et al. Quality of medical care delivered to Medicare beneficiaries: a profile at state and national levels. JAMA. 2000;284(13):1670-1676.
17. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003; 348(26):2635-2645. (Pubitemid 36741592)
18. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139. (Pubitemid 41587600)
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373-383. (Pubitemid 17055592)
20. Oaxaca R. Male-female wage differentials in urban labor markets. Int Econ Rev. 1973;14(3):693-709.
21. Blinder AS. Wage discrimination: reduced form and structural estimates. J Hum Resour. 1973;8(4):436-455.
22. Yang Z, Zhang K, Lin PJ, Clevenger C, Atherly A. A longitudinal analysis of the lifetime cost of dementia. Health Serv Res. 2012; 47(4):1660-1678.
23. Shen C, Smyer M, Mahoney KJ, et al. Consumer-directed care for beneficiaries with mental illness: lessons from New Jersey's Cash and Counseling program. Psychiatr Serv. 2008;59(11):1299-1306.
24. Foster L, Brown R, Phillips B, Carlson BL. Easing the burden of caregiving: the impact of consumer direction on primary informal caregivers in Arkansas. Gerontologist. 2005;45(4):474-485. (Pubitemid 41061065)
25. Mahoney KJ, Simon-Rusinowitz L, Simone K, Zgoda K. Cash and counseling: a promising option for consumer-direction of home and community-based services and supports. Care Manag J. 2006;7(4):199-204. (Pubitemid 44963802)
26. Foster L, Brown R, Phillips B, et al. Improving Quality of Medicaid Personal Assistance Through Consumer Direction. Princeton, NJ: Mathematica Policy Research; 2003.
27. Carlson BL, Foster L, Dale SB, Brown R. Effect of cash and counseling on personal care and well-being. Health Serv Res. 2007;42(1 pt 2):467-487. (Pubitemid 46105855)
28. Office of Program Policy Analysis and Government Accountability of Florida. The Alzheimer's Disease Waiver Program Does Not Delay Nursing Home Entry More Effectively Than Other Waivers and Costs the State More Per Participant Than Most Waivers That Serve Similar Persons. February 2010. Report No. 10-23.
29. Kuo TC, Zhao Y, Weir S, Kramer MS, Ash AS. Implications of comorbidity on costs for patients with Alzheimer disease. Med Care. 2008;46(8):839-846.
30. Fossett JW and Burke CE. Medicaid Policy and Long-Term Care Spending. Health Policy Research Center. The Nelson A. Rockefeller Institute of Government, University at Albany State University of New York. August 2010.
31. Pande A, Laditka SB, Laditka JN, Davis D. Aging in place? Evidence that a state Medicaid waiver program helps frail older persons avoid institutionalization. Home Health Care Serv Q. 2007;26(3):39-60.
32. Mucha L, Shaohung S, Cuffel B, McRae T, Mark TL, Del Valle M. Comparison of cholinesterase inhibitor utilization patterns and associated health care costs in Alzheimer's disease. JManag Care Pharm. 2008;14(5):451-461.
33. Beusterien KM, Thomas SK, Gause D, Kimel M, Arcona S, Mirski D. Impact of rivastigmine use on the risk of nursing home placement in a US sample. CNS Drugs. 2004;18(15): 1143-1148. (Pubitemid 40007496)
34. Lopez OL, Becker JT, Wisniewski S, Saxton J, Kaufer DI, DeKosky ST. Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002;72(3):310-314.
35. Knopman D, Schneider L, Davis K, et al. Long-Term tacrine (Cognex) treatment: effects on nursing home placement and mortality, tacrine study group. Neurology. 1996;47(1):166-177. (Pubitemid 26243879)
36. Joyce AT, Zhao Y, Bowman L, Flynn JA, Carter CT, Ollendorf DA. Burden of illness among commercially insured patients with Alzheimer's disease. Alzheimers Dement. 2007;3(3):204-210. (Pubitemid 46825504)
37. Schulz R, Belle SH, Czaja SJ, McGinnis KA, Stevens A, Zhang S. Long-Term care placement of dementia patients and caregiver health and well-being. JAMA. 2004;292(8):961-967. (Pubitemid 39097206)
38. McClendon MJ, Smyth KA, Neundorfer MM. Long-Term-care placement and survival of persons with Alzheimer's disease. J Gerontol B Psychol Sci Soc Sci. 2006;61(4):P220-P227. (Pubitemid 44115203)
39. Haley WE, Gitlin LN, Wisniewski SR, et al. Well-being, appraisal, and coping in African-American and Caucasian dementia caregivers: findings from the REACH study. Aging Ment Health. 2004;8(4):316-329. (Pubitemid 38954353)
40. Kominski GF, Morisky DE, Afifi AA, Kotlerman JB. The effect of disease management on utilization of services by race/ethnicity: evidence from the Florida Medicaid program. Am J Manag Care. 2008;14(3):168-172. (Pubitemid 351367360)
41. Lin PJ, Biddle AK, Ganguly R, Kaufer DI, Maciejewski ML. The concentration and persistence of health care expenditures and prescription drug expenditures in Medicare beneficiaries with Alzheimer's disease and related dementias. Med Care. 2009;47(11): 1174-1179.